Abstract:Purpose: To quantify interfractional anatomical variations and their dosimetric impact during the course of fractionated proton therapy (PT) of prostate cancer and to assess the robustness of the current treatment planning techniques.Methods: Simulation and daily in-room CT scans from ten prostate carcinoma patients were analyzed. PT treatment plans (78 Gy in 39 fractions of 2 Gy) were created on the simulation CT, delivering 25 fractions to PTV1 (expanded from prostate and seminal vesicles), followed by 14 boost fractions to PTV2 (expanded from prostate). Plans were subsequently applied to daily CT, with beams aligned to the prostate center in the sagittal plane. For five patients having a sufficiently large daily imaging volume, structure contours were manually drawn, and plans were evaluated for all CT sets. For the other five patients, the plans were evaluated for six selected fractions. The daily CT was matched to the simulation CT through deformable registration. The registration accuracy was validated for each fraction, and the three patients with a large number of accurately registered fractions were used for dose accumulation.Results: In individual fractions, the coverage of the prostate, seminal vesicles, and PTV1 was generally maintained at the corresponding prescription dose. For PTV2, the volume covered by the fractional prescription dose of 2 Gy (i.e., V2) was, on average, reduced by less than 3% compared to the simulation plan. Among the 225 (39 x 5 + 6 x 5) fractions examined, 15 showed a V2 reduction larger than 5%, of which ten were caused by a large variation in rectal gas, and five were due to a prostate shift in the craniocaudal direction. The fractional dose to the anterior rectal wall was found to increase for one patient who had large rectal gas volume in 25 of the 39 fractions, and another who experienced significant prostate volume reduction during the treatment. The fractional bladder dose generally increased with decreasing fullness. In the total accumulated dose for the three patients after excluding a few fractions with inaccurate registration due to a large amount of rectal gas (a condition inconsistent with RTOG protocol), 98.5%, 96.6%, and 98.2% of the PTV2 received the prescription dose of 78 Gy. The V75 and V70 of the anterior rectal wall and bladder both remained within tolerance.Conclusions: The results confirm that the PT planning techniques and dose constraints used at our institution ensure that target coverage to the prescription dose is maintained in the presence of interfractional anatomical variations. Dose coverage in individual fractions can be compromised, and normal tissue dose increased, due to deviations in the bladder and rectal volume compared to the simulation plans or progressive changes in the prostate volume during the treatment. Deviations from the plan can be reduced with efforts aimed at maintaining consistent daily patient anatomy. (C) 2011 American Association of Physicists in Medicine. [DOI: 10.1118/1.3604152]

[Comparison of Treatment Planning by Carbon Ion Radiotherapy and by Intensity-Modulated Radiotherapy for Prostatic Adenocarcinoma].

Treatment plan comparison of Linac step and shoot,Tomotherapy, RapidArc, and Proton therapy for prostate cancer using dosimetrical and biological index

A Comprehensive Comparison of IMRT and VMAT Plan Quality for Prostate Cancer Treatment

Comparing radiation treatments using intensity-modulated beams, multiple arcs, and single arcs.

Evaluation Of The Dosimetric Impact Of Interfractional Anatomical Variations On Prostate Proton Therapy Using Daily In-Room Ct Images

A Meta-analysis of Carbon Ion Radiotherapy for Prostate Cancer

A Dosimetric Comparative Study of Carbon-Ion Radiotherapy Versus X-ray Volumetric Modulated Arc Therapy for Stage III Non-Small-Cell Lung Cancer

Dosimetric Comparison and Selection Criteria of Intensity-Modulated Proton Therapy and Intensity-Modulated Radiation Therapy for Adaptive Re-Plan in T3-4 Nasopharynx Cancer Patients

Clinical advantages of carbon-ion radiotherapy

Preliminary Study of Intensity Modulated Radiation Therapy for Patients with Prostate Carcinoma

Dosimetric study of 3D conformal radiotherapy compared with 5F intensity modulated radiotherapy in preoperative rectum cancer

A Dosimetric Comparison Between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer

Dosimetric Study of Three Different Techniques in Postoperative Adjuvant Irradiation of Rectal Cancer

Comparison With Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Lung Cancer

Comparison of RapidArc Plans and Fixed Field Intensity Modulated Radiotherapy Planning in Cervical Cancer Radiotherapy

A Dosimetric Comparison of the Fixed-Beam IMRT Plans Using Different Leaf Width of Multileaf Collimators for the Intermediate Risk Prostate Cancer

Use of a Correlation Analysis Model in the Optimization of Intensity-Modulated Radiotherapy of Prostate Cancer.

Dosimetric Comparison of Intensity-Modulated Proton Radiotherapy Versus Intensity-Modulated Photon-Based Radiotherapy for Breast Cancer

Dosimetric and radiobiological comparison of TomoTherapy and IMRT plans for prostate cancer

Dose comparison between fix-field IMRT and VMAT in pre-operation rectum cancer radiation therapy

Comparison of the Efficacy and Toxicity of Postoperative Proton Versus Carbon Ion Radiotherapy for Head and Neck Cancers.